Issue 66, Spring 2012

In this issue
Cover story
- Every industry faces its own challenges in 2012’s turbulent economic environment. These capabilities systems could pave the way for business growth in a dozen key sectors: chemicals, industrials, aerospace, technology, automotive, pharmaceuticals, consumer packaged goods, healthcare, telecom, retail, retail banking, wealth & asset management.
The Capabilities Premium in M&A
A new study of inorganic growth shows that deals made to enhance or leverage the things that companies do well consistently outperform others.Big Pharma’s Uncertain Future
The business model that drove the major drugmakers’ success isn’t working anymore. The survivors will be those that make smart strategic bets supported by winning capabilities.Linda Rottenberg’s High-Impact Endeavor
This social entrepreneur pioneered a new model for mentoring startups in emerging markets. Now she’s replicating it around the world.The Thought Leader Interview: Bob Carrigan
Media pioneer Bob Carrigan, of IDG Communications and the Interactive Advertising Bureau, explains why new media is the most optimistic part of the economy.
Leading Ideas
The Faster New World of Healthcare
Regulatory reform and IT advances are accelerating the “clockspeed” in healthcare. To compete, insurers will need to focus on three key areas.Health Reform by the Numbers
By using data to target inefficiencies, leading healthcare systems are proving technology’s potential to revolutionize care delivery.The Innovativeness of Nations
INSEAD professor Soumitra Dutta’s Global Innovation Index helps show which nations are on the rise and which are not.Five Millennial Myths
Forget what you think you know about your Gen Y employees.A New Way to Gain Customer Insights
How conjoint analysis, a tried-and-true market research tool, can be used to support organic growth.
Essays
How to Make a Region Innovative
To foster economic growth, innovation clusters need to draw on the power of an interrelated “quad” of sectors: public, private, civil, and academic.Five Steps toward a Revitalized Pharmaceutical Supply Chain
Global drug companies are facing disruption. One powerful strategic response is to rethink their manufacturing and operations footprints.
Books in Brief
Disruptive Innovators
A review of The Innovator’s DNA, by Jeff Dyer, Hal Gregersen, and Clayton M. Christensen.Disruptive Innovation
A review of The Innovator’s Manifesto, by Michael E. Raynor.The Travails of the U.S. Auto Industry
A review of Once upon a Car, by Bill Vlasic.The Upside of Management Gurus
A review of Masters of Management, by Adrian Wooldridge.
Recent Research
Measuring the Value of Going Global
A new way to assess the pluses.